Cite
Urbán L, Dóczi R, Vodicska B, et al. Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, . J Pers Med. 2020;10(3)doi: 10.3390/jpm10030107.
Urbán, L., Dóczi, R., Vodicska, B., Kormos, D., Tóth, L., Takács, I., Várkondi, E., Tihanyi, D., Lakatos, D., Dirner, A., Vályi-Nagy, I., & Peták, I. (2020). Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, . Journal of personalized medicine, 10(3), . https://doi.org/10.3390/jpm10030107
Urbán, László, et al. "Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, ." Journal of personalized medicine vol. 10,3 (2020). doi: https://doi.org/10.3390/jpm10030107
Urbán L, Dóczi R, Vodicska B, Kormos D, Tóth L, Takács I, Várkondi E, Tihanyi D, Lakatos D, Dirner A, Vályi-Nagy I, Peták I. Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, . J Pers Med. 2020 Aug 28;10(3). doi: 10.3390/jpm10030107. PMID: 32872120; PMCID: PMC7563786.
Copy
Download .nbib